Stocksigma LogoStocksigma Logo

Gujarat Themis Biosyn Issues Clarifications on Preferential Issue

Gujarat Themis Biosyn released additional disclosures regarding its proposed preferential issue of up to 82,10,786 equity shares (face value ₹1 each) at

Gujarat Themis Biosyn Issues Clarifications on Preferential Issue

Gujarat Themis Biosyn Ltd · Others (Uncategorized) · 04 Nov 2026, 11:13 pm

Gujarat Themis Biosyn Issues Clarifications on Preferential Issue Gujarat Themis Biosyn released additional disclosures regarding its proposed preferential issue of up to 82,10,786 equity shares (face value ₹1 each) at ₹408 per share to secure in-principle stock exchange approval. The company clarified that the 12-month timeline for utilizing issue proceeds starts from the share allotment date. It also identified ultimate beneficial owners for proposed allottees: Special Situation India Fund (Srinath Narasimhan, Pankaj Kalra, Jigar Karania) and India Special Assets Fund III alongside ISAF III Onshore Fund (Amit Agarwal, Navin Sambtani, Kriti Ghosh).

Original exchange filing (PDF)

More announcements from Gujarat Themis Biosyn Ltd

All Gujarat Themis Biosyn Ltd announcements